Procalcitonin Predicts Response to Beta-Lactam Treatment in Hospitalized Children with Community-Acquired Pneumonia

• Jérémie F. Cohen ,

  * E-mail: jeremie.cohen@inserm.fr

  Affiliations Department of Pediatrics, Saint-Vincent-de-Paul and Necker-Enfants-Malades Hospital, AP–HP, Université Paris-Descartes, Paris, France, Epidemiological Research Unit on Perinatal Health and Women's and Children's Health (U953), Inserm, Paris, France

  ⨯
• Alexander Leis,

  Affiliation Epidemiological Research Unit on Perinatal Health and Women's and Children's Health (U953), Inserm, Paris, France

  ⨯
• Thibault Lecarpentier,

  Affiliation Department of Pediatrics, Saint-Vincent-de-Paul and Necker-Enfants-Malades Hospital, AP–HP, Université Paris-Descartes, Paris, France

  ⨯
• Josette Raymond,

  Affiliation Department of Microbiology, Cochin Hospital, AP–HP, Université Paris-Descartes, Paris, France

  ⨯
• Dominique Gendrel,

  Affiliation Department of Pediatrics, Saint-Vincent-de-Paul and Necker-Enfants-Malades Hospital, AP–HP, Université Paris-Descartes, Paris, France

  ⨯
• Martin Chalumeau

  Affiliations Department of Pediatrics, Saint-Vincent-de-Paul and Necker-Enfants-Malades Hospital, AP–HP, Université Paris-Descartes, Paris, France, Epidemiological Research Unit on Perinatal Health and Women's and Children's Health (U953), Inserm, Paris, France

  ⨯